Scinai Immunotherapeutics SCNI
NASDAQ SCNI
$0.47 +0.03 (+6.82%)
At close: Nov 9, 2026 · 4:00 PM EST

Scinai Immunotherapeutics (SCNI) Receivables - Other (2022 - 2025)

Updated

Scinai Immunotherapeutics (SCNI) recorded Receivables - Other of $152,000 in Q4 2023, down 1.9% from $155,000 a year earlier.

Analysis

Scinai Immunotherapeutics (SCNI) Receivables - Other (2022 - 2025) Analysis & Trends

Starting with Q4 2021, Scinai Immunotherapeutics' Receivables - Other history includes 4 quarters.

  • Across earlier years, Receivables - Other came in at $155,000 in FY2022 (-52.5%) and $326,000 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn
10 Scinai Immunotherapeutics 112,563.86 -8.15 Mn -1.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -7.25 Mn
Dec 31, 2023 152,000.00
Jun 30, 2023 5.83 Mn
Dec 31, 2022 155,000.00
API Access

Scinai Immunotherapeutics Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=SCNI&period=max&api_key=YOUR_API_KEY